ArisEurope, ICON, Syneos Health, Accenture, IQVIA, Genpact, Cognizant, Paraxel International, Laboratory Corporation of ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price negotiations, federal health officials announced Friday. The negotiations for ...

While the resulting product, Pluvicto, has already been approved by the US Food and Drug Administration (FDA), the new study, if successful ... the FDA accepted it and Daiichi Sankyo’s joint ...

to the most approved drugs with a new active substance in 2024. On 15 January, the two agencies released respective lists of medicines approved last year. The FDA approved 50 novel drugs that ...

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Please provide your email address to receive an email when new articles are posted on ... episodes and nighttime blood pressure (BP). The drug’s safety profile in this specific patient ...

Today, the Governments of Canada and the province of New Brunswick signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $32 million over three years to improve access ...

announced a bilateral agreement investing over $32 million to improve access to selected new drugs for rare diseases, and to support enhanced access to existing drugs, early diagnosis, and screening.

The application was refiled following a December 20, 2024, meeting between the US Food and Drug Administration (FDA) and Astellas. The US Food and Drug Administration (FDA) has accepted the revised ...

Subscribe here to receive future editions. The U.S. Food and Drug Administration wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. That's according to the ...

CVS Caremark will add Zydus’ Zituvio and combination products to its template formulary starting ... of Zydus’ strategic investments in the new drug applications portfolio.